Hamid Ghanadan on CRISPR Cuts

We’ve been tracking how COVID-19 is uniquely affecting the life science community — and particularly how a pandemic causes disruption to scientific progress. In an episode on Synthego’s CRISPR Cuts, Founder Hamid Ghanadan discusses this impact and shared the initial results of our longitudinal study on coronavirus and its immediate effects.